Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs

PHASE2CompletedINTERVENTIONAL

Enrollment

125

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL

Meningococcal (vaccine)

Trial Locations (1)

GSK Investigational Site, Thuin